92 related articles for article (PubMed ID: 9600142)
1. [Development of resistance and utilization of fluoroquinolones in a university hospital].
Vlcek J; Pozlerová E; Lonská V; Kotlár J
Ceska Slov Farm; 1997 Oct; 46(5):195-8. PubMed ID: 9600142
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
3. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
Kern WV; Steib-Bauert M; de With K; Reuter S; Bertz H; Frank U; von Baum H
J Antimicrob Chemother; 2005 Jan; 55(1):57-60. PubMed ID: 15574472
[TBL] [Abstract][Full Text] [Related]
5. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of antibiotic consumption in an intensive care burn department].
Thabet L; Bousselmi K; Oueslati S; Memmi M; Ben Redjeb S; Messadi AA
Tunis Med; 2007 Dec; 85(12):1035-8. PubMed ID: 19170383
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of trends in ue of antibiotics and resistance in selected bacterial pathogens].
Perlík F; Jedlicková A; Práznovcová L
Cas Lek Cesk; 2002 Apr; 141(7):220-2. PubMed ID: 12053758
[TBL] [Abstract][Full Text] [Related]
8. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
Tayfour M; Yuce A; Yulug N
Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
[TBL] [Abstract][Full Text] [Related]
9. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
Gottesman BS; Carmeli Y; Shitrit P; Chowers M
Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
[TBL] [Abstract][Full Text] [Related]
11. [Fluoroquinolone resistance of human pathogenic bacteria. Resistant E coli now appearing in Sweden].
Osterlund A; Olsson-Liljequist B
Lakartidningen; 1999 Apr; 96(16):1965-6. PubMed ID: 10330864
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
Payerl-Pal M
Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
[TBL] [Abstract][Full Text] [Related]
13. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
14. Correlating antibiotic consumption with antimicrobial resistance of uropathogens in a university teaching hospital in Lagos, Nigeria.
Oduyebo OO; Onwuezobe IA; Olayemi SO; Akintunde AS
Niger J Clin Pract; 2008 Dec; 11(4):305-8. PubMed ID: 19320399
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
16. Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000.
Shannon KP; French GL
J Antimicrob Chemother; 2004 May; 53(5):818-25. PubMed ID: 15028663
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
18. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
Jónsdóttir K; Kristinsson KG
Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of resistance patterns of gram-negative rods from personal clinical materials].
Kedzierska J; Dolezal M; Kachlik P
Med Dosw Mikrobiol; 1999; 51(1-2):113-22. PubMed ID: 10865437
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
